American health technology company
Tempus AI, Inc. (formerly Tempus Labs [ 1] health technology company[ 2] Eric Lefkofsky in Chicago , Illinois.[ 3] breast cancer .[ 4] artificial intelligence (AI) to create precision medicine services, including diagnostics,[ 5] oncology , cardiology , radiology , and depression. The company went public on the Nasdaq on June 14, 2024, under the ticker symbol "TEM."[ 6] [ 7]
Business
Tempus does genome sequencing and precision medicine, including diagnostics, primarily for cancer patients, as well as for cardiology patients, radiology, and pharmacogenomic testing for patients with depression.[ 8] [ 9]
Tempus investors include SoftBank Group , Baillie Gifford , New Enterprise Associates , Novo Holdings , Franklin Templeton Investments , T. Rowe Price , Revolution LLC , Google LLC , and others.[ 10]
In June 2024, Tempus and SoftBank formed an AI healthcare joint venture in Japan called SB Tempus with a plan to develop personalized treatment recommendations by analyzing medical data with AI.[ 11] [ 12] [ 13]
The company's advisory board includes Jennifer Doudna and Scott Gottlieb .[ 1] [ 14]
References
^ a b Pletz, John (November 12, 2021). "A Tempus IPO will give Lefkofsky a shot at post-Groupon redemption" . Crain's Chicago Business ^ "16. Tempus" . CNBC ^ Rosenbaum, Leah (December 10, 2020). "EXCLUSIVE: Billionaire Eric Lefkofsky's Tempus Raises $200 Million to Bring Personalized Medicine to New Diseases" . Forbes ^ Liu, Phoebe. "Billionaire Groupon Founder Eric Lefkofsky's Health Tech Company Goes Public—His Fourth IPO" . Forbes . Retrieved June 20, 2024 . ^ Or, Amy (June 14, 2024). "Medical Data Firm Tempus AI Rises After $410.7 Million IPO" . Bloomberg . ^ de León, Riley (June 14, 2024). "Google-backed Tempus AI closes first day of trading up 9% in Nasdaq stock market debut" . CNBC ^ de León, Riley (June 14, 2024). "Google-backed Tempus AI closes first day of trading up 9% in Nasdaq stock market debut" . CNBC ^ "AI-enabled precision medicine" . tempus.com . Tempus. Retrieved January 30, 2025 .^ Eans, Zachary (August 4, 2021). "Chicago-based precision medicine company plans 200-job expansion into RTP" . The News & Observer ^ "SoftBank-backed Tempus AI seeks up to $6.1 bln valuation in US IPO" . Reuters ^ Bridge, Anton (June 27, 2024). "SoftBank Group launches AI healthcare joint venture with Tempus AI" . Reuters . ^ Park, Kate (June 27, 2024). "SoftBank forms AI healthcare JV in Japan with Tempus" . TechCrunch ^ Asplund, Jon (November 4, 2024). "Tempus buying genetics lab company for $600 million" . Crain's Chicago Business ^ Liu, Phoebe (October 17, 2024). "The Billionaire Behind Groupon Is Making A Fortune In An Industry He Swore He'd Never Enter" . Forbes
